Status: Not yet recruiting
A Single and Multiple Ascending Dose Escalation and Food Effect Study of QX-4533 in Healthy Participants
The primary purpose of this study is to evaluate the safety and tolerability of QX-4533 following oral administration of single and multiple ascending doses in healthy participants.
Participants needed: 90
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: QuantX Biosciences, Inc.Updated: Jul 1, 2026Locations: 1
Eligibility criteria
Male or female between 18 and 55 years of age (inclusive) at screening. [+4]
History or presence of significant cardiovascular, pulmonary, hepatic, renal, he... [+8]